» Articles » PMID: 31191728

Does Ambulatory Oxygen Improve Quality of Life in Patients with Fibrotic Lung Disease? Results from the AmbOx Trial

Overview
Journal Breathe (Sheff)
Specialty Pulmonary Medicine
Date 2019 Jun 14
PMID 31191728
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

http://ow.ly/uHC030nEzsz.

Citing Articles

Functional Measures in Non-COPD Chronic Respiratory Diseases: A Systematic Review.

Zamboti C, Pimpao H, Bertin L, Krinski G, Garcia T, Dos Santos Filho S J Clin Med. 2024; 13(22).

PMID: 39598031 PMC: 11595047. DOI: 10.3390/jcm13226887.


Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease.

Lawrence A, Myall K, Mukherjee B, Marino P Life (Basel). 2024; 14(9).

PMID: 39337985 PMC: 11433497. DOI: 10.3390/life14091203.

References
1.
Jones P, Quirk F, Baveystock C . The St George's Respiratory Questionnaire. Respir Med. 1991; 85 Suppl B:25-31; discussion 33-7. DOI: 10.1016/s0954-6111(06)80166-6. View

2.
Patel A, Siegert R, Brignall K, Gordon P, Steer S, Desai S . The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax. 2012; 67(9):804-10. DOI: 10.1136/thoraxjnl-2012-201581. View

3.
Patel A, Siegert R, Keir G, Bajwah S, Barker R, Maher T . The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med. 2013; 107(9):1438-43. DOI: 10.1016/j.rmed.2013.06.009. View

4.
Richeldi L, du Bois R, Raghu G, Azuma A, Brown K, Costabel U . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2071-82. DOI: 10.1056/NEJMoa1402584. View

5.
King Jr T, Bradford W, Castro-Bernardini S, Fagan E, Glaspole I, Glassberg M . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370(22):2083-92. DOI: 10.1056/NEJMoa1402582. View